Cargando…

Geographical Accessibility of the Sarcoma Referral Networks in France. Intermediate Results from the IGéAS Research Program

Rare cancer patients face lower survival and experience delays in diagnosis and therapeutic mismanagement. Considering the specificities of rare cancers, referral networks have been implemented in France to improve the management and survival of patients. The IGéAS research program aims to assess th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fayet, Yohan, Coindre, Jean-Michel, Dalban, Cécile, Gouin, François, De Pinieux, Gonzague, Farsi, Fadila, Ducimetière, Françoise, Chemin-Airiau, Claire, Jean-Denis, Myriam, Chabaud, Sylvie, Blay, Jean-Yves, Ray-Coquard, Isabelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210416/ https://www.ncbi.nlm.nih.gov/pubmed/30308955 http://dx.doi.org/10.3390/ijerph15102204

Ejemplares similares

Impact of the coronavirus disease 2019 pandemic on sarcoma management in France: a 2019 and 2020 comparison
por: Penel, Nicolas, et al.
Publicado: (2023)

No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks’ Outcome?
por: Fayet, Yohan, et al.
Publicado: (2022)

Correction to: Beyond the map: evidencing the spatial dimension of health inequalities
por: Fayet, Yohan, et al.
Publicado: (2021)

Beyond the map: evidencing the spatial dimension of health inequalities
por: Yohan, Fayet, et al.
Publicado: (2020)

ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case–control study—study protocol
por: Lacourt, Aude, et al.
Publicado: (2019)

The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group
por: Perrier, Lionel, et al.
Publicado: (2018)

P043 - Délais de prise en charge des sarcomes au sein des centres labellisés NETSARC+ pendant l’épidémie de COVID-19 et analyse des déterminants: étude COV-PEC-SARC
por: Cantarel, C., et al.
Publicado: (2023)

Gender equality in the Italian academic context. Results from the IGEA project
por: Deiana, Giovanna, et al.
Publicado: (2023)

Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network
por: de Pinieux, Gonzague, et al.
Publicado: (2021)

Determinants of the access to remote specialised services provided by national sarcoma reference centres
por: Fayet, Yohan, et al.
Publicado: (2021)

Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort
por: Roth, Gaël S., et al.
Publicado: (2022)

Transferability of health cost evaluation across locations in oncology: cluster and principal component analysis as an explorative tool
por: Perrier, Lionel, et al.
Publicado: (2014)

The immune landscape of chondrosarcoma reveals an immunosuppressive environment in the dedifferentiated subtypes and exposes CSFR1+ macrophages as a promising therapeutic target
por: Iseulys, Richert, et al.
Publicado: (2019)

Ictal Generalized EEG Attenuation (IGEA) and hypopnea in a child with occipital type 1 cortical dysplasia – Is it a biomarker for SUDEP?
por: Chaitanya, Ganne, et al.
Publicado: (2015)

Medium levels of transcription and replication related chromosomal instability are associated with poor clinical outcome
por: Benhaddou, Ataaillah, et al.
Publicado: (2021)

Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS)
por: Ray-Coquard, Isabelle, et al.
Publicado: (2017)

Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions
por: Perrier, Lionel, et al.
Publicado: (2012)

Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma
por: Dantas-Barbosa, Carmela, et al.
Publicado: (2017)

Refining Prognosis in Localized Gastrointestinal Stromal Tumor: Clinical Significance of Phosphatase and Tensin Homolog Low Expression and Gene Loss
por: Feng, Xiaolan, et al.
Publicado: (2022)

Deep learning predicts patients outcome and mutations from digitized histology slides in gastrointestinal stromal tumor
por: Fu, Yu, et al.
Publicado: (2023)

Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region
por: Lurkin, Antoine, et al.
Publicado: (2010)

Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients
por: Duffaud, Florence, et al.
Publicado: (2012)

Distinct Cellular Origins and Differentiation Process Account for Distinct Oncogenic and Clinical Behaviors of Leiomyosarcomas
por: Darbo, Elodie, et al.
Publicado: (2023)

Molecular Mechanisms of Kaposi Sarcoma Development
por: Karabajakian, Andy, et al.
Publicado: (2022)

Characterization of Macrophages and Osteoclasts in the Osteosarcoma Tumor Microenvironment at Diagnosis: New Perspective for Osteosarcoma Treatment?
por: Gomez-Brouchet, Anne, et al.
Publicado: (2021)

Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?
por: Ménétrier-Caux, Christine, et al.
Publicado: (2019)

Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT)
por: Brahmi, Mehdi, et al.
Publicado: (2020)

Management of Patients with Pancreatic Ductal Adenocarcinoma in the Real-Life Setting: Lessons from the French National Hospital Database
por: de la Fouchardière, Christelle, et al.
Publicado: (2021)

Being treated in higher volume hospitals leads to longer progression-free survival for epithelial ovarian carcinoma patients in the Rhone-Alpes region of France
por: Huguet, Marius, et al.
Publicado: (2018)

Validation of prognostic scores for survival in cancer patients beyond first-line therapy
por: Trédan, Olivier, et al.
Publicado: (2011)

A case of IgE myeloma transformed into IgE-producing plasma cell leukaemia
por: Galakhoff, Nicolas, et al.
Publicado: (2019)

Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort)
por: Derbel, Olfa, et al.
Publicado: (2017)

Cancer screening in France: subjects’ and physicians’ attitudes
por: Eisinger, François, et al.
Publicado: (2007)

Risk of death of patients with cancer presenting with severe symptoms of infection, with or without documented COVID-19: In reply to van Dam et al.
por: Assaad, Souad, et al.
Publicado: (2020)

Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
por: Ducimetière, Françoise, et al.
Publicado: (2011)

Low-grade extraskeletal osteosarcoma of the chest wall: case report and review of literature
por: Sabatier, Renaud, et al.
Publicado: (2010)

Expanding the molecular spectrum of tenosynovial giant cell tumors
por: Gauduchon, Thibault, et al.
Publicado: (2022)

Intraosseous Hibernoma: A Rare Entity in Orthopedics With Peculiar Radiological Features
por: Samargandi, Ramy, et al.
Publicado: (2023)

Pregnancy in Women with Metastatic Sarcomas
por: Yazigi, Alexandre, et al.
Publicado: (2020)

Cutaneous Epithelioid Clear Cells Angiosarcoma in a Young Woman with Congenital Lymphedema
por: Tabareau-Delalande, Flore, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8sjt7csr5q6cb69hmk6j8jvs1f